For patients in the early stages of multiple sclerosis , low levels of vitamin D were found to strongly predict disease severity and hasten its progression, according to a new study led by Harvard School of Public Health investigators in collaboration with Bayer HealthCare.
http://ift.tt/KBLqef
http://ift.tt/KBLqef
